Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy

The magnitude of the host immune response can be regulated by either stimulatory or inhibitory immune checkpoint molecules. Receptor-ligand binding between inhibitory molecules is often exploited by tumours to suppress anti-tumour immune responses. Immune checkpoint inhibitors that block these inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhe, Mowday, Alexandra M., Smaill, Jeff B., Hermans, Ian F., Patterson, Adam V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146304/
https://www.ncbi.nlm.nih.gov/pubmed/33923305
http://dx.doi.org/10.3390/cells10051006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146304/
https://www.ncbi.nlm.nih.gov/pubmed/33923305
http://dx.doi.org/10.3390/cells10051006

Ejemplares similares